Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies

Documenti analoghi

• Impact of prior COVID‐19 infection on allogeneic hematopoietic stem cell transplantation outcomes
  di: Aleksandr Siniaev, et al.
  Pubblicazione: (2024)
• Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients
  di: Binbin Lv, et al.
  Pubblicazione: (2024)
• Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
  di: Maria Alejandra Mendoza, et al.
  Pubblicazione: (2024)
• Letermovir use may impact on the Cytomegalovirus DNA fragmentation profile in plasma from allogeneic hematopoietic stem cell transplant recipients
  di: Estela Giménez, et al.
  Pubblicazione: (2024)
• Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
  di: Jieling Jiang, et al.
  Pubblicazione: (2024)